Rectal Cancer News

CancerConnect rectal cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of rectal cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of rectal cancer treatment and survivorship.

Share

Rectal Cancer News


Web Chat on “Using Radiation to Treat Colorectal Cancers Metastasized to the Liver,” with Sarah Cannon Expert Andrew Kennedy, MD (April 2, 2014)

  Sarah Cannon Radiation Oncology Physician-in-Chief Andrew Kennedy, MD, discusses metastatic colorectal cancer and answers participants’ questions during a live Web chat recorded on April 2, 2014.... Continue Reading

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal... Continue Reading

Stool Test Spots Most Colon Cancers (February 19, 2014)

A stool test known as the fecal immunochemical test (FIT) is accurate in diagnosing most colorectal cancers, according to a meta-analysis published in the Annals of Internal Medicine. Screening is crucial... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

Understanding Ostomies (November 20, 2013)

An ostomy is a general term for a surgically created opening from the inside of the body to the outside. For people with colorectal cancer, an ostomy may be necessary after surgery to remove part or all... Continue Reading

Vectibix is Not Inferior to Erbitux in Wild-Type KRAS Metastatic Colorectal Cancer (October 18, 2013)

Vectibix® (panitumumab) was non-inferior to Erbitux® (cetuximab) for overall survival in the treatment of wild-type KRAS metastatic colorectal cancer in patients who have not responded to chemotherapy,... Continue Reading

Colorectal Cancer Screening Works Over Long-Term (October 4, 2013)

The results of a study published in the New England Journal of Medicine, suggest that it pays to follow colorectal cancer screening recommendations—and people who do follow the guidelines are less likely... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact,... Continue Reading

Low-Dose Aspirin Reduces Colon Cancer Risk in Women (August 7, 2013)

Women who take a low-dose aspirin every other day have a reduced risk of colon cancer, according to the results of a study published in the Annals of Internal Medicine—however, the benefit carries with... Continue Reading

More Rectal Cancer News

Latest Rectal Cancer News By Stage


Screening and Prevention

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Stool Test Spots Most Colon Cancers (February 19, 2014)

A stool test known as the fecal immunochemical test (FIT) is accurate in diagnosing most colorectal cancers, according to a meta-analysis published in the Annals of Internal Medicine. Screening is crucial for the prevention and early detection of colorectal... Continue Reading

Colorectal Cancer Screening Works Over Long-Term (October 4, 2013)

The results of a study published in the New England Journal of Medicine, suggest that it pays to follow colorectal cancer screening recommendations—and people who do follow the guidelines are less likely to develop colon cancer than people who do not. Colorectal... Continue Reading

Low-Dose Aspirin Reduces Colon Cancer Risk in Women (August 7, 2013)

Women who take a low-dose aspirin every other day have a reduced risk of colon cancer, according to the results of a study published in the Annals of Internal Medicine—however, the benefit carries with it a risk of gastrointestinal bleeding.[1] Colorectal... Continue Reading

Biomarker Could Potentially Help Detect Colorectal Cancer (July 29, 2013)

Blood levels of miR-21, a piece of DNA known as microRNA, could serve as a promising biomarker for the early detection and prognosis of colorectal cancer, according to the results of a study published in the Journal of the National Cancer Institute. Colorectal... Continue Reading

More Screening and Prevention

Stages I-III

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading

Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)

Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal of Clinical Oncology. Colorectal cancer is the second... Continue Reading

Rectal Cancer Patients May Benefit from Higher Dose of Preoperative Radiation (October 12, 2011)

Among rectal cancer patients treated with chemotherapy and radiation therapy prior to surgery, providing a higher dose of radiation therapy (50 Gy rather than 45 Gy) may reduce the risk of cancer recurrence. These results were presented at the 53rd Annual... Continue Reading

African Americans Most Willing to Exhaust Resources for Life-Extending Care (May 5, 2011)

African Americans who are diagnosed with lung or colorectal cancer may be more willing than Whites to expend all personal financial resources in order to extend their lives. Other minority groups also appear more likely than Whites to use personal resources.... Continue Reading

More Stages I-III

Stage IV

Web Chat on “Using Radiation to Treat Colorectal Cancers Metastasized to the Liver,” with Sarah Cannon Expert Andrew Kennedy, MD (April 2, 2014)

  Sarah Cannon Radiation Oncology Physician-in-Chief Andrew Kennedy, MD, discusses metastatic colorectal cancer and answers participants’ questions during a live Web chat recorded on April 2, 2014. Topics  include: Difficulties of treating mCRC Treatment... Continue Reading

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing delivery of treatment could improve treatment... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Vectibix is Not Inferior to Erbitux in Wild-Type KRAS Metastatic Colorectal Cancer (October 18, 2013)

Vectibix® (panitumumab) was non-inferior to Erbitux® (cetuximab) for overall survival in the treatment of wild-type KRAS metastatic colorectal cancer in patients who have not responded to chemotherapy, according to the results of a study presented at... Continue Reading

Erbitux Plus Chemo Boosts Survival in Patients with Colorectal Cancer and Liver Metastases (May 29, 2013)

Adding Erbitux® (cetuximab) to standard chemotherapy might allow some patients with colorectal cancer and inoperable liver metastases to undergo successful surgical resection of the liver metastasis, according to the results of a study published in the... Continue Reading

More Stage IV

Recurrent/Relapsed

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing delivery of treatment could improve treatment... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Vectibix is Not Inferior to Erbitux in Wild-Type KRAS Metastatic Colorectal Cancer (October 18, 2013)

Vectibix® (panitumumab) was non-inferior to Erbitux® (cetuximab) for overall survival in the treatment of wild-type KRAS metastatic colorectal cancer in patients who have not responded to chemotherapy, according to the results of a study presented at... Continue Reading

Erbitux Plus Chemo Boosts Survival in Patients with Colorectal Cancer and Liver Metastases (May 29, 2013)

Adding Erbitux® (cetuximab) to standard chemotherapy might allow some patients with colorectal cancer and inoperable liver metastases to undergo successful surgical resection of the liver metastasis, according to the results of a study published in the... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading

More Recurrent/Relapsed

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS